glp-1 treatment new orleans ​"Triple-Hormone" Drug Shows Record Weight Loss: At the American Diabetes Association's 2026 Scientific Sessions, researchers unveiled phase 3 trial results for retatrutide, the first therapy to GLP-1 Drugs Lower Risk of

The platform uses asynchronous provider consultations meaning you communicate with a medical provider via messaging rather than live video calls and ships medications directly to patients

If you're building out a full protocol that includes multiple peptides alongside BAC water vials, our peptide starter kit guide walks through what to have on hand and how to plan your supply to minimize waste

Treatment is accessible through HSA/FSA accounts, and our team provides prior authorization support for insurance coverage

Garber, AJ, Abrahamson MJ, Barzilay Jl, et al

Curious to see how this evolves and what the real-world results look like over time.